Dividend-adjusted total return · S&P 500 uses VOO · Dec 31, 2025 – Nov 3, 2026IBBS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +0.8% | +3.6% | +12.3% | +27.8% | +35.5% | +93.1% | +36.3% | +728.7% |
| Peer average | +1.1% | −9.6% | −6.2% | +8.6% | +5.3% | +90.4% | +32.3% | — |
| S&P 500 · VOO | +0.3% | −2.6% | −1.7% | +11.5% | +11.9% | +90.9% | +77.5% | — |
Key Statistics
Open all fund facts →- AUM
- $11.2B
- Expense ratio
- 0.44%
- Distribution yield
- 0.2%
- NAV
- $215.42
- Volume
- 1.7M
- Avg. volume 30D
- 1.8M
- High today
- $218.12
- Low today
- $214.52
- Previous close
- $213.79
- 52-week high
- $222.29
- 52-week low
- $154.62
- Our risk indicator
- 4/5
IBB in One Breath
IBB Among Technology ETFs
YTDEnd-of-day Nov 4, 2026 · 54 Technology ETFs by YTD
$10,000 in IBB
5Y$10,000 in IBB became
$13,634
In the S&P 500 (VOO)
$17,749
Total return, dividends in · Oct 26, 2021 – Nov 3, 2026 · S&P 500 uses VOO
IBB’s Top Holdings
TodayGILDGilead Sciences8.9%AMGN8.3%VRTX7.9%REGN6.2%MRNA5.5%NTRA3.8%ARGX3.4%BIIB2.5%RVMD2.5%ILMN2.4%GMAB2.1%ONC2.1%UTHR1.7%INSM1.6%INCY1.6%ALNY1.5%ROIV1.3%CRL1.2%EXEL1.1%ASNDHALONBIX221 more
GILDGilead Sciences8.9%AMGN8.3%VRTX7.9%REGN6.2%MRNA5.5%NTRA3.8%ARGX3.4%BIIB2.5%RVMD2.5%ILMN2.4%GMAB2.1%ONC231 more
BiotechnologyDrug Manufacturers - GeneralMedical - Diagnostics
iShares IBB · 243 holdings · tile size = share of the fund · as of Nov 3, 2026
What IBB Holds
TodayBiotechnology63.1%
VRTX 7.9 · REGN 6.2 · MRNA 5.5 · ARGX 3.4 · RVMD 2.5 · GMAB 2.1 · ONC 2.1
Drug Manufacturers - General19.9%
GILD 8.9 · AMGN 8.3 · BIIB 2.5 · GRFS
Medical - Diagnostics & Research9.3%
NTRA 3.8 · ILMN 2.4 · CRL 1.2 · MEDP · GRAL · CDNA · VCYT
Medical - Instruments & Supplies0.7%
RGEN
Medical - Healthcare Information Services0.5%
TEM
Drug Manufacturers - Specialty & Generic0.5%
ALKS
Medical - Devices0.4%
BRKR
iShares IBB · share of the fund by industry · as of Nov 3, 2026
Gilead’s Share of IBB
Today8.9%
$89 of every $1,000 in IBB is Gilead
Gilead held by IBB
$1.0B
iShares IBB · each square = $10 of $1,000 · as of Nov 3, 2026
IBB’s Share of Technology ETFs
Today3.1%
of the $366B in 58 Technology ETFs
$11.2B3.1%
$155B42.3%
$115B31.5%
$84.8B23.2%
Technology ETF AUM · Nov 4, 2026
IBB Fee per $100 vs Peers
TodayExpense ratio · Technology peers · Nov 4, 2026
Inside IBB
243 holdings · as of Nov 3, 2026IBB
iShares Biotechnology ETF
Today| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 8.94% |
| 2 | AMGN | Amgen | 8.31% |
| 3 | VRTX | Vertex Pharmaceuticals | 7.87% |
| 4 | REGN | Regeneron Pharmaceuticals | 6.24% |
| 5 | MRNA | Moderna | 5.49% |
| 6 | NTRA | Natera | 3.78% |
| 7 | ARGX | Argenx SE | 3.36% |
| 8 | BIIB | Biogen | 2.52% |
| 9 | RVMD | Revolution Medicines | 2.50% |
| 10 | ILMN | Illumina | 2.41% |
BiotechnologyDrug Manufacturers - GeneralMedical - DiagnosticsMedical - InstrumentsMedical - Healthcare Information ServicesDrug Manufacturers - SpecialtyMedical - DevicesOther
iShares IBB · current holdings by weight · as of Nov 3, 2026 · each tile is one holding · top 20 = 66.8%
How It Compares
IBB
iShares Biotechnology ETF’s Peers
TodayTechnology peers · Today’s and past-year returns · as of Nov 4, 2026 · sorted by AUM
Head to Head
Put IBB head to head with VGT →VGT vs IBB
YTDYear to date
IBB wins+5.0 pts
Past year
IBB wins+18.7 pts
Fee
VGT winslower fee
Yield
VGT wins+0.3 pts
AUM
VGT13.7× more
2–2level
Vanguard VGT and iShares IBB · year-to-date · as of Nov 4, 2026 · AUM not scored
IBB vs VOO
YTDIBB · iShares Biotechnology
+27.8%
VOO · S&P 500
+11.5%
Gap
16.2 pts
iShares IBB and Vanguard VOO · Today total return · as of Nov 4, 2026
IBB vs Its Peer Average
YTDIBBAvsBPeer average
1D+0.8%+1.1%
1M+3.6%−9.6%
3M+12.3%−6.2%
YTD+27.8%+8.6%
1Y+35.5%+5.3%
3Y+93.1%+90.4%
5Y+36.3%+32.3%
6–1IBB wins
57 Technology peers · each row scaled to its leader
The Details
IBB
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y22.73%
Deepest drop · 1Y−9.6%
Lowest point · 5Y−33.5%
52-week range
$215.47
$154.62−3.1% from the high$222.29
iShares IBB · past-year price moves · as of Nov 4, 2026
IBB
Fund Facts
Today2001launched Feb 5
Tracks[…]
Exchange · CUSIPNASDAQ · 464287556
StructureETF
Leverage1x
Cost on $10,000$44 a year
Go deeper
iShares IBB · fund facts · as of Nov 4, 2026
IBB
Payouts by Year
13Y$0.0112per share, Sep 2026
Distribution yield0.2%
PaidEvery quarter
Latest ex-date · paidSep 15 · Sep 18, 2026
12 payouts added up$1.22 a share
iShares IBB · distributions by ex-date · 2014–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
Trading & Liquidity
Net asset value$215.42
Premium / discount[…]
Median spread · 30D[…]
Volume today1.7M
Average volume · 30D1.8M
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.44%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$44.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.0112 |
| Jun 15, 2026 | Jun 18, 2026 | $0.0238 |
| Mar 17, 2026 | Mar 20, 2026 | $0.12 |
| Dec 16, 2025 | Dec 19, 2025 | $0.18 |
| Sep 16, 2025 | Sep 19, 2025 | $0.0828 |
| Mar 18, 2025 | Mar 21, 2025 | $0.12 |
| Dec 17, 2024 | Dec 20, 2024 | $0.0624 |
| Sep 25, 2024 | Sep 30, 2024 | $0.20 |
| Mar 21, 2024 | Mar 27, 2024 | $0.13 |
| Dec 20, 2023 | Dec 27, 2023 | $0.12 |
| Sep 26, 2023 | Oct 2, 2023 | $0.15 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0062 |
Issuer contentFrom iSharesHear the strategy from the people behind IBB.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →